NYSE - Delayed Quote USD

Cameco Corporation (CCJ)

48.76 +0.08 (+0.16%)
At close: April 24 at 4:00 PM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 7699
Avg. Estimate 0.220.180.91.32
Low Estimate 0.150.110.590.8
High Estimate 0.320.261.262.02
Year Ago EPS 0.2-0.010.570.9

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 2276
Avg. Estimate 604.69M545.36M2.23B2.28B
Low Estimate 602.98M506.03M2.04B2.1B
High Estimate 606.4M584.68M2.4B2.64B
Year Ago Sales 531.53M349.4M1.89B2.23B
Sales Growth (year/est) 13.80%56.10%18.00%2.40%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. 0.190.090.090.16
EPS Actual 0.2-0.010.240.15
Difference 0.01-0.10.15-0.01
Surprise % 5.30%-111.10%166.70%-6.30%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate 0.220.180.91.32
7 Days Ago 0.210.180.891.31
30 Days Ago 0.240.210.971.21
60 Days Ago 0.240.210.981.22
90 Days Ago 0.280.291.191.31

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days 1------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD CCJIndustrySectorS&P 500
Current Qtr. 10.00%----1.50%
Next Qtr. 1,900.00%----11.40%
Current Year 57.90%----5.20%
Next Year 46.70%----13.40%
Next 5 Years (per annum) 48.31%----11.09%
Past 5 Years (per annum) -8.06%------

Research Analysis

Analyst Price Targets

40.14 Low
52.70 Average
48.76 Current
59.29 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Initiated Goldman Sachs: Buy 4/1/2024
Maintains TD Securities: Action List Buy to Action List Buy 10/3/2023
Maintains GLJ Research: Buy to Buy 9/12/2023
Maintains B of A Securities: Buy to Buy 9/5/2023
Maintains Canaccord Genuity: Buy to Buy 9/5/2023
Maintains Raymond James: Outperform to Outperform 8/3/2023

Related Tickers